SPHK1 and pulmonary fibrosis: We previously showed that concurrent treatment of mice with a nonspecific SPHK1 inhibitor, SK1-II, at the time of bleomycin exposure reduces lung fibrosis in a manner similar to that seen in the Sphk1-/- mice [15,21].